Results 221 to 230 of about 427,642 (386)

Health-promoting effects of <i>Clostridium butyricum</i> GKB7 on the gastrointestinal tract in murine models. [PDF]

Biochem Biophys Rep
Tsai YS, Chen CC, Lee LY, Lin SW, Chen YL, Chen CC.   +5 more
europepmc   +1 more source

Clostridium difficile and One Health.

Clinical Microbiology and Infection, 2020
S. Lim, D. Knight, Thomas V. Riley
semanticscholar   +1 more source

Calcium butyrate efficacy in pediatric irritable bowel syndrome: Randomized placebo‐controlled multiomics‐based clinical trial

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders, and treatment involves nonpharmacological and pharmacological therapies, even if there is no optimal therapy. This randomized, placebo‐controlled, double‐blind trial aimed to evaluate the efficacy of calcium butyrate supplementation in ...
Fernanda Cristofori, Francesco Maria Calabrese, Ilaria Iacobellis, Monica Santamaria, Giuseppe Celano, Ilario Ferrocino, Emanuela Di Sabato, Rocco Pergola, Vanessa N. Dargenio, Leonardo Paulucci, Maria De Angelis, Ruggiero Francavilla   +11 more
wiley   +1 more source

Feasibility of blood self-sampling with HemaSpot HF for Anti-Clostridium tetani Toxin IgG detection. [PDF]

Sci Rep
Kettlitz R, Ortmann J, Kerrinnes T, Ott JJ, Castell S.   +4 more
europepmc   +1 more source

GROWTH REQUIREMENTS OF CLOSTRIDIUM TETANI

, 1941
J. Howard Mueller, Pauline A. Miller
openalex   +1 more source

The proteinases of Clostridium histolyticum [PDF]

, 1940
W. E. van Heyningen
openalex   +1 more source

Have we hit the JAK‐pot? Success of selective JAK 1 inhibitor following failure of pan‐JAK inhibitor in refractory pediatric ulcerative colitis

JPGN Reports, EarlyView.
Abstract The treatment options available for pediatric ulcerative colitis (UC) are challenging due to few with Federal Drug Administration approval. Newer medications approved for adults include additional biologics with differing mechanisms of action and small molecule drugs, such as Janus kinase (JAK) inhibitors.
Jessica A. Black, Brad Pasternak
wiley   +1 more source

Gut microbial utilization of the alternative sweetener, D-allulose, via AlsE. [PDF]

Commun Biol
Minabou Ndjite G, Jiang AK, Ravel CT, Grant MR, Jiang X, Hall B.   +5 more
europepmc   +1 more source

The Products Resulting from the Putrefaction of Fibrin by Clostridium Carno-Foetidus, Salus and Rauschbrand

, 1910
Francis H. McCrudden
openalex   +1 more source

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

New England Journal of Medicine, 2017
M. Wilcox, D. Gerding, I. Poxton, C. Kelly, Richard Nathan, T. Birch, O. Cornely, G. Rahav, E. Bouza, Christine H. Lee, G. Jenkin, Werner Jensen, You-Sun Kim, J. Yoshida, Lori Gabryelski, Alison Pedley, K. Eves, R. Tipping, D. Guris, N. Kartsonis, M. Dorr   +20 more
semanticscholar   +1 more source